Our Team Members

Ilonka van Hoof, PhD

Ilonka van Hoof is a toxicologist by training and has over 20 years’ experience in Nonclinical drug development/Toxicology and over 10 years’ experience in services in early drug development (consultancy, operational support) with clients ranging from start-up companies to big pharma. She has over 10 years’ experience with project management, program management, and line management. She has worked on many different indications and has experience in NCE as well as NBE development. Her expertise includes activities ranging from overall non-clinical consultancy for PK/TK, safety pharmacology and toxicology studies, GAP analyses and due diligences, preparing non-clinical drug development plans, outsourcing and monitoring of non-clinical development programs as a sponsor representative to writing of/contributing to non-clinical documents for regulatory submissions. She has a broad understanding of the drug development (regulatory) requirements as well as extensive knowledge of the ICH/GxP guidelines. Ilonka holds a PhD degree in Molecular Pharmacology from the VU, Amsterdam


Non clinical drug development/ toxicology